Skip to main content
. 2023 Jan 7;17:123–134. doi: 10.2147/OPTH.S399044

Table 2.

Comparison Between the A and B Groups After Screen-Time Reduction

Parameters Group A (Mean ± SD)
Median (Range)
Group B (Mean ± SD)
Median (Range)
Mean Difference (Group B-Group A) (95% Confidence of Interval) P value
Daily screen-hours (hours): 1±0 1±0 0
1 (1:1) 1 (1:1)
Visual outcomes (logMAR):
UDVA 0.12±0.19 0.23±0.22 0.11 (−0.01:0.23) 0.06
0.1 (−0.2:0.6) 0.2 (−0.2:0.7)
CDVA −0.08±0.09 −0.04±0.06 0.04 (−0.006:0.08) 0.09
−0.1 (−0.3:0) 0 (−0.2:0)
mfERG second examination outcomes:
I- Amplitudes P1:
(normal range nV/deg2)
Ring 1 88.14±15.46 70.50±12.30 −17.64 (−25.59:-9.70) <0.0001
R1 (66.6–130.8) 88.37 (63.12:138.75) 67.37 (45.43:100.1)
Ring 2 38.97±5.89 37.92±7.16 −1.05 (−4.78:2.68) 0.57
R2 (30.9–77.8) 36.68 (31.78:57.86) 36.45 (27.36:52.96)
Ring 3 22.98±3.04 24.18±4.46 1.19 (−0.98:3.36) 0.25
R3 (21.7–59) 22.46 (16.68:30.28) 23.69 (16.33:33.4)
Ring 4 13.78±2.29 12.28±2.36 −1.50 (−2.82:-0.18) 0.03
R4 (12.9–37.1) 13.33 (10.46:18.52) 12.22 (8.34:19.03)
Ring 5 11.84±2.31 9.21±2.05 −2.34 (−3.58:-1.10) 0.0004
R5 (10–28.2) 10.88 (8.35:18.97) 8.68 (6.7:14.95)
II- Amplitudes P1:
(normal range nV/deg2)
Quadrant 1 13.00±2.25 12.46±3.17 −0.54 (−2.10:1.01) 0.49
Q1 (15.8–42.74) 12.57 (9.35:18.26) 11.89 (5.67:21.79)
Quadrant 2 16.69±2.01 13.72±2.79 −2.96 (−4.35:-1.59) 0.0001
Q2 (15.98–42.75) 16.89 (12.46:20.46) 13.67 (8.56:19.41)
Quadrant 3 16.66±3.17 15.69±3.57 −0.97 (−2.89:0.95) 0.31
Q3 (15.18–42.05) 15.56 (12.68:23.47) 15.34 (8.45:22.41)
Quadrant 4 12.29±2.00 10.16±2.52 −2.14 (−3.43:0.84) 0.002
Q4 (13.87–39.61) 11.89 (9:15.86) 9.87 (6.36:14.62)

Abbreviations: UDVA, uncorrected visual acuity; CDVA, uncorrected visual acuity; logMAR, logarithm of minimal angle of resolution; Amplitudes P1, amplitude density of the first foveal peak; deg, degree; nV, nanovolts; R1 to R5, Ring 1 to Ring 5; Q1 to Q4, Quadrant 1 to Quadrant 4; SD, standard deviation.